Wellcome Trust’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-750,000
Closed -$31.7M 24
2016
Q4
$31.7M Sell
750,000
-250,000
-25% -$9.45M 0.63% 21
2016
Q3
$32.1M Hold
1,000,000
0.67% 22
2016
Q2
$26M Hold
1,000,000
0.59% 23
2016
Q1
$25M Hold
1,000,000
0.55% 23
2015
Q4
$31.8M Hold
1,000,000
0.63% 27
2015
Q3
$31.5M Hold
1,000,000
0.7% 25
2015
Q2
$38.8M Buy
1,000,000
+500,000
+100% +$19M 0.79% 26
2015
Q1
$17.8M Hold
500,000
0.38% 25
2014
Q4
$19.4M Hold
500,000
0.4% 28
2014
Q3
$17.3M Hold
500,000
0.36% 28
2014
Q2
$16.2M Hold
500,000
0.39% 28
2014
Q1
$15.6M Buy
500,000
+100,000
+25% +$3.09M 0.38% 26
2013
Q4
$12.5M Hold
400,000
0.33% 23
2013
Q3
$10.8M Sell
400,000
-300,000
-43% -$8.05M 0.36% 22
2013
Q2
$17.1M Buy
+700,000
New +$16.6M 0.6% 20

Other funds holding MS

Wellcome Trust's MS Position: Q2 2020 in Review

Wellcome Trust sold out of Morgan Stanley (MS) in Q2 2020, closing a stake of 8,000,000 shares — an estimated $272M sold.

Wellcome Trust first reported a position in MS in Q2 2013 and held it in 28 quarters. The position peaked at $456M in Q1 2018. 1,103 funds tracked by Wall St. Rank hold MS as of Q2 2020.

  • Wellcome Trust reported no remaining Morgan Stanley position as of Q2 2020 after selling out during the quarter.
  • Wellcome Trust sold 8,000,000 Morgan Stanley shares in Q2 2020, an estimated $272M.
  • Wellcome Trust first reported a position in Morgan Stanley in Q2 2013 and held it in 28 quarters.
  • Wellcome Trust's Morgan Stanley position peaked at $456M in Q1 2018.
  • 1,103 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2020.

Based on Wellcome Trust's 13F filing for Q2 2020, filed 10 Jul 2020.